首页 > 最新文献

JTCVS open最新文献

英文 中文
Long-term outcomes of primary surgical repair for communicating DeBakey IIIb chronic dissecting aortic aneurysm 沟通型 DeBakey IIIb 慢性主动脉夹层动脉瘤初次手术修复的长期疗效
Pub Date : 2024-08-01 DOI: 10.1016/j.xjon.2024.05.009
Shuhei Miura MD, Yutaka Iba MD, PhD, Kei Mukawa MD, Keitaro Nakanishi MD, Takakimi Mizuno MD, Ayaka Arihara MD, Tsuyoshi Shibata MD, PhD, Junji Nakazawa MD, PhD, Tomohiro Nakajima MD, PhD, Nobuyoshi Kawaharada MD, PhD

Objective

This study aimed to evaluate the long-term outcomes of surgical strategies for communicating DeBakey IIIb chronic dissecting aortic aneurysm, considering the optimal primary surgical repair to prevent aortic events.

Methods

From 2002 to 2021, 101 patients with communicating DeBakey IIIb chronic dissecting aortic aneurysm who underwent surgical repair were categorized based on the primary surgical repair: 1-stage repair of thoracoabdominal aortic aneurysm (TAAAR) (n = 22) or staged repair, such as descending thoracic aneurysm repair (DTAR) (n = 43) or total arch replacement with elephant trunk implantation (TARET) (n = 25), and thoracic endovascular aortic repair (TEVAR) (n = 11). Early and late postoperative outcomes were compared among the groups.

Results

Early outcomes for TAAAR, DTAR, TARET, and TEVAR were associated with the incidence of stroke (9.1% vs 0% vs 4.0% vs 9.1%, respectively), spinal cord injury (13.6% vs 4.7% vs 8.0% vs 0%, respectively), and in-hospital mortality (9.1% vs 2.3% vs 0% vs 9.1%, respectively). During follow-up, the 10-year overall survival and 7-year aortic event-free rates for TAAAR, DTAR, TARET, and TEVAR were 61.8%, 71.6%, 21.5%, and 26.5% and 93.8%, 84.3%, 74.4%, and 51.4%, respectively. TAAAR had significantly higher overall survival (P = .05) and aortic event-free rates (P = .03) than TEVAR. TARET (hazard ratio, 2.27; P < .01) and TEVAR (hazard ratio, 3.40; P < .01) were independently associated with the incidence of aortic events during follow-up.

Conclusions

Considering the optimal primary surgical repair based on long-term outcomes, TEVAR was not a durable treatment option. Patient-specific TAAAR or DTAR should be considered rather than defaulting to minimally invasive primary repairs for all patients with communicating DeBakey IIIb chronic dissecting aortic aneurysm.

本研究旨在评估沟通型DeBakey IIIb慢性剥离性主动脉瘤手术策略的长期疗效,同时考虑到预防主动脉事件的最佳主要手术修复方法。方法从2002年到2021年,101例沟通型DeBakey IIIb慢性剥离性主动脉瘤患者接受了手术修复,根据主要手术修复方法进行分类:一期胸腹主动脉瘤修补术(TAAAR)(22 例)或分期修补术,如降胸动脉瘤修补术(DTAR)(43 例)或象鼻干植入全弓置换术(TARET)(25 例),以及胸腔内血管主动脉修补术(TEVAR)(11 例)。结果TAAAR、DTAR、TARET和TEVAR的早期结果与中风(分别为9.1% vs 0% vs 4.0% vs 9.1%)、脊髓损伤(分别为13.6% vs 4.7% vs 8.0% vs 0%)和院内死亡率(分别为9.1% vs 2.3% vs 0% vs 9.1%)相关。在随访期间,TAAAR、DTAR、TARET和TEVAR的10年总生存率和7年无主动脉事件发生率分别为61.8%、71.6%、21.5%和26.5%,以及93.8%、84.3%、74.4%和51.4%。TAAAR 的总生存率(P = .05)和无主动脉事件发生率(P = .03)明显高于 TEVAR。TARET(危险比,2.27;P <.01)和 TEVAR(危险比,3.40;P <.01)与随访期间主动脉事件的发生率独立相关。对于所有患有交流性DeBakey IIIb型慢性剥脱性主动脉瘤的患者,应考虑针对患者的TAAAR或DTAR,而不是默认采用微创初级修复术。
{"title":"Long-term outcomes of primary surgical repair for communicating DeBakey IIIb chronic dissecting aortic aneurysm","authors":"Shuhei Miura MD,&nbsp;Yutaka Iba MD, PhD,&nbsp;Kei Mukawa MD,&nbsp;Keitaro Nakanishi MD,&nbsp;Takakimi Mizuno MD,&nbsp;Ayaka Arihara MD,&nbsp;Tsuyoshi Shibata MD, PhD,&nbsp;Junji Nakazawa MD, PhD,&nbsp;Tomohiro Nakajima MD, PhD,&nbsp;Nobuyoshi Kawaharada MD, PhD","doi":"10.1016/j.xjon.2024.05.009","DOIUrl":"10.1016/j.xjon.2024.05.009","url":null,"abstract":"<div><h3>Objective</h3><p>This study aimed to evaluate the long-term outcomes of surgical strategies for communicating DeBakey IIIb chronic dissecting aortic aneurysm, considering the optimal primary surgical repair to prevent aortic events.</p></div><div><h3>Methods</h3><p>From 2002 to 2021, 101 patients with communicating DeBakey IIIb chronic dissecting aortic aneurysm who underwent surgical repair were categorized based on the primary surgical repair: 1-stage repair of thoracoabdominal aortic aneurysm (TAAAR) (n = 22) or staged repair, such as descending thoracic aneurysm repair (DTAR) (n = 43) or total arch replacement with elephant trunk implantation (TARET) (n = 25), and thoracic endovascular aortic repair (TEVAR) (n = 11). Early and late postoperative outcomes were compared among the groups.</p></div><div><h3>Results</h3><p>Early outcomes for TAAAR, DTAR, TARET, and TEVAR were associated with the incidence of stroke (9.1% vs 0% vs 4.0% vs 9.1%, respectively), spinal cord injury (13.6% vs 4.7% vs 8.0% vs 0%, respectively), and in-hospital mortality (9.1% vs 2.3% vs 0% vs 9.1%, respectively). During follow-up, the 10-year overall survival and 7-year aortic event-free rates for TAAAR, DTAR, TARET, and TEVAR were 61.8%, 71.6%, 21.5%, and 26.5% and 93.8%, 84.3%, 74.4%, and 51.4%, respectively. TAAAR had significantly higher overall survival (<em>P</em> = .05) and aortic event-free rates (<em>P</em> = .03) than TEVAR. TARET (hazard ratio, 2.27; <em>P</em> &lt; .01) and TEVAR (hazard ratio, 3.40; <em>P</em> &lt; .01) were independently associated with the incidence of aortic events during follow-up.</p></div><div><h3>Conclusions</h3><p>Considering the optimal primary surgical repair based on long-term outcomes, TEVAR was not a durable treatment option. Patient-specific TAAAR or DTAR should be considered rather than defaulting to minimally invasive primary repairs for all patients with communicating DeBakey IIIb chronic dissecting aortic aneurysm.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"20 ","pages":"Pages 1-13"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624001293/pdfft?md5=12a1cfd48f6c60ac1e3e2435c9c36f1e&pid=1-s2.0-S2666273624001293-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141960983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prophylaxis for postoperative atrial fibrillation: Impact of the implementation of a medication bundle protocol 术后心房颤动的预防:实施药物捆绑协议的影响
Pub Date : 2024-08-01 DOI: 10.1016/j.xjon.2024.05.014
{"title":"Prophylaxis for postoperative atrial fibrillation: Impact of the implementation of a medication bundle protocol","authors":"","doi":"10.1016/j.xjon.2024.05.014","DOIUrl":"10.1016/j.xjon.2024.05.014","url":null,"abstract":"","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"20 ","pages":"Pages 37-39"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624001591/pdfft?md5=26cf9000887935c40e2eb7753a65ff45&pid=1-s2.0-S2666273624001591-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141391214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Timing of coronary artery bypass grafting after myocardial infarction influences late survival 心肌梗死后冠状动脉旁路移植手术的时机影响晚期存活率
Pub Date : 2024-08-01 DOI: 10.1016/j.xjon.2024.05.008

Objectives

The role of timing of coronary artery bypass grafting after acute myocardial infarction on early and late outcomes remains uncertain.

Methods

We reviewed 1631 consecutive adult patients who underwent isolated coronary artery bypass grafting with information on timing of acute myocardial infarction. Early and late mortality were compared between patients receiving coronary artery bypass grafting within 24 hours after acute myocardial infarction, between 1 and 7 days after acute myocardial infarction, and more than 7 days after acute myocardial infarction. Sensitivity analyses were performed in subgroups of patients with ST-segment elevation myocardial infarction or non–ST-segment elevation myocardial infarction, and other high-risk groups.

Results

A total of 124 patients (5.7%) underwent coronary artery bypass grafting within 24 hours, 972 patients (51.2%) received coronary artery bypass grafting between 1 and 7 days after acute myocardial infarction, and 535 patients (43.2%) underwent coronary artery bypass grafting more than 7 days after acute myocardial infarction. Overall operative mortality was 2.7% with comparable adjusted early mortality among 3 groups. Over a median follow-up of 13.5 years (interquartile range, 8.9-17.1), compared with patients receiving coronary artery bypass grafting between 1 and 7 days after acute myocardial infarction, those receiving coronary artery bypass grafting at 7 days had greater adjusted risk for late overall mortality (hazard ratio, 1.39, 95% CI, 1.16-1.67; P < .001), whereas those receiving coronary artery bypass grafting within 24 hours had comparable risk of late overall mortality (hazard ratio, 1.12, 95% CI, 0.86-1.47; P = .39). Timing of coronary artery bypass grafting was associated with late mortality in patients with non–ST-segment elevation myocardial infarction (patients receiving coronary artery bypass grafting at >7 days had a higher risk of late mortality [hazard ratio, 1.38, 95% CI, 1.14-1.67, P < .001] compared with those receiving coronary artery bypass grafting between 1 and 7 days), but not in patients with ST-segment elevation myocardial infarction.

Conclusions

Early revascularization through coronary artery bypass grafting within 7 days during the same hospitalization appears beneficial, especially for patients presenting with non–ST-segment elevation myocardial infarction.

急性心肌梗死后冠状动脉旁路移植手术的时机对早期和晚期预后的影响仍不确定。方法我们对 1631 例连续接受孤立冠状动脉旁路移植手术的成年患者进行了回顾性研究,并了解了急性心肌梗死的时机。我们比较了急性心肌梗死后 24 小时内、急性心肌梗死后 1-7 天内和急性心肌梗死后 7 天以上接受冠状动脉旁路移植术的患者的早期和晚期死亡率。对 ST 段抬高型心肌梗死或非 ST 段抬高型心肌梗死患者及其他高危人群进行了敏感性分析。结果 共有124名患者(5.7%)在急性心肌梗死后24小时内接受了冠状动脉旁路移植术,972名患者(51.2%)在急性心肌梗死后1至7天内接受了冠状动脉旁路移植术,535名患者(43.2%)在急性心肌梗死后7天以上接受了冠状动脉旁路移植术。手术总死亡率为 2.7%,三组患者的调整后早期死亡率相当。在中位 13.5 年(四分位间范围为 8.9-17.1)的随访中,与急性心肌梗死后 1-7 天内接受冠状动脉旁路移植术的患者相比,7 天内接受冠状动脉旁路移植术的患者晚期总死亡率的调整风险更高(危险比为 1.39,95% CI,1.16-1.67;P <.001),而在 24 小时内接受冠状动脉旁路移植术的患者晚期总死亡率风险相当(危险比,1.12,95% CI,0.86-1.47;P = .39)。冠状动脉旁路移植术的时间与非 ST 段抬高型心肌梗死患者的晚期死亡率有关(7 天内接受冠状动脉旁路移植术的患者晚期死亡风险更高[危险比为 1.38,95% CI 为 1.14-1.67,P < .结论在同一住院期间,通过在 7 天内进行冠状动脉旁路移植术进行早期血管再通似乎是有益的,尤其是对于非 ST 段抬高型心肌梗死患者。
{"title":"Timing of coronary artery bypass grafting after myocardial infarction influences late survival","authors":"","doi":"10.1016/j.xjon.2024.05.008","DOIUrl":"10.1016/j.xjon.2024.05.008","url":null,"abstract":"<div><h3>Objectives</h3><p>The role of timing of coronary artery bypass grafting after acute myocardial infarction on early and late outcomes remains uncertain.</p></div><div><h3>Methods</h3><p>We reviewed 1631 consecutive adult patients who underwent isolated coronary artery bypass grafting with information on timing of acute myocardial infarction. Early and late mortality were compared between patients receiving coronary artery bypass grafting within 24 hours after acute myocardial infarction, between 1 and 7 days after acute myocardial infarction, and more than 7 days after acute myocardial infarction. Sensitivity analyses were performed in subgroups of patients with ST-segment elevation myocardial infarction or non–ST-segment elevation myocardial infarction, and other high-risk groups.</p></div><div><h3>Results</h3><p>A total of 124 patients (5.7%) underwent coronary artery bypass grafting within 24 hours, 972 patients (51.2%) received coronary artery bypass grafting between 1 and 7 days after acute myocardial infarction, and 535 patients (43.2%) underwent coronary artery bypass grafting more than 7 days after acute myocardial infarction. Overall operative mortality was 2.7% with comparable adjusted early mortality among 3 groups. Over a median follow-up of 13.5 years (interquartile range, 8.9-17.1), compared with patients receiving coronary artery bypass grafting between 1 and 7 days after acute myocardial infarction, those receiving coronary artery bypass grafting at 7 days had greater adjusted risk for late overall mortality (hazard ratio, 1.39, 95% CI, 1.16-1.67; <em>P &lt;</em> .001), whereas those receiving coronary artery bypass grafting within 24 hours had comparable risk of late overall mortality (hazard ratio, 1.12, 95% CI, 0.86-1.47; <em>P =</em> .39). Timing of coronary artery bypass grafting was associated with late mortality in patients with non–ST-segment elevation myocardial infarction (patients receiving coronary artery bypass grafting at &gt;7 days had a higher risk of late mortality [hazard ratio, 1.38, 95% CI, 1.14-1.67, <em>P</em> &lt; .001] compared with those receiving coronary artery bypass grafting between 1 and 7 days), but not in patients with ST-segment elevation myocardial infarction.</p></div><div><h3>Conclusions</h3><p>Early revascularization through coronary artery bypass grafting within 7 days during the same hospitalization appears beneficial, especially for patients presenting with non–ST-segment elevation myocardial infarction.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"20 ","pages":"Pages 40-48"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624001281/pdfft?md5=b852b8ef74d7f9907ec44d4e6128256e&pid=1-s2.0-S2666273624001281-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141139212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Salvage lung resection after immunotherapy is feasible and safe 免疫疗法后的挽救性肺切除术既可行又安全
Pub Date : 2024-08-01 DOI: 10.1016/j.xjon.2024.03.018

Objectives

Patients with non–small cell lung cancer treated with immunotherapy and modern chemoradiation regimens show improved progression-free and overall survival. However, patients with limited oligo-progression represent a potential population in which local therapy such as surgery may have a potential role as salvage treatment. The objectives of our study were to evaluate the feasibility and safety of salvage lung resection after immunotherapy in patients with non–small cell lung cancer.

Methods

The National Cancer Database was queried for patients diagnosed and treated for non–small cell lung cancer stage I to IV, from 2013 to 2020. Patients who underwent surgery as salvage after immunotherapy were defined as undergoing surgery >5 months from the initiation of immunotherapy. As a sensitivity analysis, patients who underwent surgery as salvage after chemoradiation were also analyzed in a similar fashion. Surgical outcomes such as type of surgery, complete resection (R0) rates, and complete pathologic response rates were determined for feasibility. Length of stay, 30-day readmission rates, and 30-day mortality rates were determined and overall survivals were estimated with Kaplan-Meier analysis to evaluate for safety.

Results

Of the 934,093 patients diagnosed with non–small cell lung cancer stage I to IV from 2013 to 2020, 164 patients received immunotherapy and after 5 months underwent surgery. Lobectomy was the most commonly performed operation (74%) and pneumonectomy was required in 9% (n = 15). R0 resection was achieved in 89% (n = 146) and of these patients, 23% (n = 37) had complete pathologic response. Median length of stay was 4 days, 30-day readmission was 5%, and 30-day mortality was 0.6%. In our sensitivity analysis of chemoradiation patients (n = 445), the above data were similar to previously reported cohort studies of patients undergoing chemoradiation and subsequently salvage surgery.

Conclusions

Lung resection after immunotherapy appears to be a feasible salvage treatment option, with lobectomy being most common and with high R0 resection rates. Low patient morbidity and mortality rates also suggest the safety of this approach. Salvage surgery may be considered in patients who have oligo-progression after immunotherapy within the context of a comprehensive multidisciplinary treatment plan.

目标接受免疫疗法和现代化疗方案治疗的非小细胞肺癌患者的无进展生存期和总生存期均有所改善。然而,局限性少见进展的患者是局部治疗(如手术)可能作为挽救性治疗发挥作用的潜在人群。我们的研究目的是评估非小细胞肺癌患者接受免疫疗法后进行挽救性肺切除术的可行性和安全性。方法查询美国国家癌症数据库,了解 2013 年至 2020 年期间诊断和治疗的 I 至 IV 期非小细胞肺癌患者。免疫治疗后接受手术作为挽救治疗的患者被定义为在开始免疫治疗5个月后接受手术>。作为一项敏感性分析,化疗后作为挽救手段接受手术的患者也以类似方式进行了分析。手术类型、完全切除率(R0)和完全病理反应率等手术结果都是根据可行性确定的。研究还确定了住院时间、30 天再入院率和 30 天死亡率,并采用卡普兰-梅耶尔分析法估算了总生存率,以评估其安全性。肺叶切除术是最常见的手术(74%),9%的患者需要进行肺切除术(n = 15)。89%的患者(146人)实现了R0切除,其中23%的患者(37人)获得了完全病理反应。中位住院时间为 4 天,30 天再入院率为 5%,30 天死亡率为 0.6%。在我们对化疗患者(n = 445)进行的敏感性分析中,上述数据与之前报道的接受化疗并随后接受挽救手术的患者队列研究相似。患者的低发病率和低死亡率也表明了这种方法的安全性。在多学科综合治疗计划的背景下,免疫治疗后出现寡进展的患者可考虑进行挽救性手术。
{"title":"Salvage lung resection after immunotherapy is feasible and safe","authors":"","doi":"10.1016/j.xjon.2024.03.018","DOIUrl":"10.1016/j.xjon.2024.03.018","url":null,"abstract":"<div><h3>Objectives</h3><p>Patients with non–small cell lung cancer treated with immunotherapy and modern chemoradiation regimens show improved progression-free and overall survival. However, patients with limited oligo-progression represent a potential population in which local therapy such as surgery may have a potential role as salvage treatment. The objectives of our study were to evaluate the feasibility and safety of salvage lung resection after immunotherapy in patients with non–small cell lung cancer.</p></div><div><h3>Methods</h3><p>The National Cancer Database was queried for patients diagnosed and treated for non–small cell lung cancer stage I to IV, from 2013 to 2020. Patients who underwent surgery as salvage after immunotherapy were defined as undergoing surgery &gt;5 months from the initiation of immunotherapy. As a sensitivity analysis, patients who underwent surgery as salvage after chemoradiation were also analyzed in a similar fashion. Surgical outcomes such as type of surgery, complete resection (R0) rates, and complete pathologic response rates were determined for feasibility. Length of stay, 30-day readmission rates, and 30-day mortality rates were determined and overall survivals were estimated with Kaplan-Meier analysis to evaluate for safety.</p></div><div><h3>Results</h3><p>Of the 934,093 patients diagnosed with non–small cell lung cancer stage I to IV from 2013 to 2020, 164 patients received immunotherapy and after 5 months underwent surgery. Lobectomy was the most commonly performed operation (74%) and pneumonectomy was required in 9% (n = 15). R0 resection was achieved in 89% (n = 146) and of these patients, 23% (n = 37) had complete pathologic response. Median length of stay was 4 days, 30-day readmission was 5%, and 30-day mortality was 0.6%. In our sensitivity analysis of chemoradiation patients (n = 445), the above data were similar to previously reported cohort studies of patients undergoing chemoradiation and subsequently salvage surgery.</p></div><div><h3>Conclusions</h3><p>Lung resection after immunotherapy appears to be a feasible salvage treatment option, with lobectomy being most common and with high R0 resection rates. Low patient morbidity and mortality rates also suggest the safety of this approach. Salvage surgery may be considered in patients who have oligo-progression after immunotherapy within the context of a comprehensive multidisciplinary treatment plan.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"20 ","pages":"Pages 141-150"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624001128/pdfft?md5=ffaf91ee55dcf62366d75060b2116206&pid=1-s2.0-S2666273624001128-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140769501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of nonemergency cardiac surgery after overnight operative workload: A statewide experience 非急诊心脏手术在通宵手术后的效果:全州经验
Pub Date : 2024-08-01 DOI: 10.1016/j.xjon.2024.04.018
Tyler M. Bauer MD , Michael J. Pienta MD , Xiaoting Wu PhD , Michael P. Thompson PhD , Robert B. Hawkins MD , Andrew L. Pruitt MD , Alphonse Delucia III MD , Shelly C. Lall MD , Francis D. Pagani MD, PhD , Donald S. Likosky PhD , The Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative and The Video Assessment of CaRdiac Surgery QualITY (VARSITY) Surgery Investigators

Objective

Cardiac surgeons experience unpredictable overnight operative responsibilities, with variable rest before same-day, first-start scheduled cases. This study evaluated the frequency and associated impact of a surgeon's overnight operative workload on the outcomes of their same-day, first-start operations.

Methods

A statewide cardiac surgery quality database was queried for adult cardiac surgical operations between July 1, 2011, and March 1, 2021. Nonemergency, first-start, Society of Thoracic Surgeons predicted risk of mortality operations were stratified by whether or not the surgeon performed an overnight operation that ended after midnight. A generalized mixed effect model was used to evaluate the effect of overnight operations on a Society of Thoracic Surgeons composite outcome (5 major morbidities or operative mortality) of the first-start operation.

Results

Of all first-start operations, 0.4% (239/56,272) had a preceding operation ending after midnight. The Society of Thoracic Surgeons predicted risk of morbidity and mortality was similar for first-start operations whether preceded by an overnight operation or not (overnight operation: 11.3%; no overnight operation: 11.7%, P = .42). Unadjusted rates of the primary outcome were not significantly different after an overnight operation (overnight operation: 13.4%; no overnight operation: 12.3%, P = .59). After adjustment, overnight operations did not significantly impact the risk of major morbidity or mortality for first-start operations (adjusted odds ratio, 1.1, P = .70).

Conclusions

First-start cardiac operations performed after an overnight operation represent a small subset of all first-start Society of Thoracic Surgeons predicted risk operations. Overnight operations do not significantly influence the risk of major morbidity or mortality of first-start operations, which suggests that surgeons exercise proper judgment in determining appropriate workloads.

目的:心脏外科医生的通宵手术责任难以预测,他们在当日首次手术前的休息时间也不尽相同。本研究评估了外科医生通宵手术工作量的频率及其对当天首次手术结果的相关影响。方法查询了 2011 年 7 月 1 日至 2021 年 3 月 1 日期间全州心脏外科质量数据库中的成人心脏外科手术。根据外科医生是否进行了午夜后结束的通宵手术,对非急诊、首次启动、胸外科医师协会预测的死亡风险手术进行了分层。采用广义混合效应模型来评估隔夜手术对胸外科医师学会首次启动手术的综合结果(5 种主要疾病或手术死亡率)的影响。结果 在所有首次启动的手术中,0.4%(239/56,272 例)的前次手术在午夜后结束。根据胸外科医师协会的预测,首次启动手术的发病率和死亡率风险相似,无论之前是否有过夜手术(过夜手术:11.3%;无过夜手术:11.7%,P = .42)。隔夜手术后,主要结果的未调整率没有显著差异(隔夜手术:13.4%;未隔夜手术:12.3%,P = 0.59)。经过调整后,隔夜手术对首次手术的主要发病率或死亡率风险没有明显影响(调整后的几率比为 1.1,P = .70)。结论在隔夜手术后进行的首次心脏手术是胸外科医师学会预测风险的所有首次手术中的一小部分。通宵手术对首次手术的重大发病率或死亡率风险没有明显影响,这表明外科医生在确定适当的工作量时应做出正确判断。
{"title":"Outcomes of nonemergency cardiac surgery after overnight operative workload: A statewide experience","authors":"Tyler M. Bauer MD ,&nbsp;Michael J. Pienta MD ,&nbsp;Xiaoting Wu PhD ,&nbsp;Michael P. Thompson PhD ,&nbsp;Robert B. Hawkins MD ,&nbsp;Andrew L. Pruitt MD ,&nbsp;Alphonse Delucia III MD ,&nbsp;Shelly C. Lall MD ,&nbsp;Francis D. Pagani MD, PhD ,&nbsp;Donald S. Likosky PhD ,&nbsp;The Michigan Society of Thoracic and Cardiovascular Surgeons Quality Collaborative and The Video Assessment of CaRdiac Surgery QualITY (VARSITY) Surgery Investigators","doi":"10.1016/j.xjon.2024.04.018","DOIUrl":"10.1016/j.xjon.2024.04.018","url":null,"abstract":"<div><h3>Objective</h3><p>Cardiac surgeons experience unpredictable overnight operative responsibilities, with variable rest before same-day, first-start scheduled cases. This study evaluated the frequency and associated impact of a surgeon's overnight operative workload on the outcomes of their same-day, first-start operations.</p></div><div><h3>Methods</h3><p>A statewide cardiac surgery quality database was queried for adult cardiac surgical operations between July 1, 2011, and March 1, 2021. Nonemergency, first-start, Society of Thoracic Surgeons predicted risk of mortality operations were stratified by whether or not the surgeon performed an overnight operation that ended after midnight. A generalized mixed effect model was used to evaluate the effect of overnight operations on a Society of Thoracic Surgeons composite outcome (5 major morbidities or operative mortality) of the first-start operation.</p></div><div><h3>Results</h3><p>Of all first-start operations, 0.4% (239/56,272) had a preceding operation ending after midnight. The Society of Thoracic Surgeons predicted risk of morbidity and mortality was similar for first-start operations whether preceded by an overnight operation or not (overnight operation: 11.3%; no overnight operation: 11.7%, <em>P</em> = .42). Unadjusted rates of the primary outcome were not significantly different after an overnight operation (overnight operation: 13.4%; no overnight operation: 12.3%, <em>P</em> = .59). After adjustment, overnight operations did not significantly impact the risk of major morbidity or mortality for first-start operations (adjusted odds ratio, 1.1, <em>P</em> = .70).</p></div><div><h3>Conclusions</h3><p>First-start cardiac operations performed after an overnight operation represent a small subset of all first-start Society of Thoracic Surgeons predicted risk operations. Overnight operations do not significantly influence the risk of major morbidity or mortality of first-start operations, which suggests that surgeons exercise proper judgment in determining appropriate workloads.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"20 ","pages":"Pages 101-111"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624001323/pdfft?md5=8a565e6b4333b3659f512bfb94eb7b11&pid=1-s2.0-S2666273624001323-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141960994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Involving the next generation of cardiovascular surgeons 让下一代心血管外科医生参与进来
Pub Date : 2024-08-01 DOI: 10.1016/j.xjon.2024.05.012
Vincent Q. Sier MSc , Joris J. Blok MD, PhD , Ferdi Akca MD, PhD , Jesper Hjortnaes MD, PhD , Joost R. van der Vorst MD, PhD
{"title":"Involving the next generation of cardiovascular surgeons","authors":"Vincent Q. Sier MSc ,&nbsp;Joris J. Blok MD, PhD ,&nbsp;Ferdi Akca MD, PhD ,&nbsp;Jesper Hjortnaes MD, PhD ,&nbsp;Joost R. van der Vorst MD, PhD","doi":"10.1016/j.xjon.2024.05.012","DOIUrl":"10.1016/j.xjon.2024.05.012","url":null,"abstract":"","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"20 ","pages":"Page 210"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624001335/pdfft?md5=8033c79bed00a27961ffc9df5eb1c620&pid=1-s2.0-S2666273624001335-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141961058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Persistent income-based disparities in clinical outcomes of cardiac surgery across the United States: A contemporary appraisal 美国心脏外科临床结果中持续存在的收入差距:当代评估
Pub Date : 2024-08-01 DOI: 10.1016/j.xjon.2024.05.015
Sara Sakowitz MS, MPH , Syed Shahyan Bakhtiyar MD, MBE , Saad Mallick MD , Arjun Verma BS , Yas Sanaiha MD , Richard Shemin MD , Peyman Benharash MD

Objective

Although national efforts have aimed to improve the safety of inpatient operations, income-based inequities in surgical outcomes persist, and the evolution of such disparities has not been examined in the contemporary setting. We sought to examine the association of community-level household income with acute outcomes of cardiac procedures over the past decade.

Methods

All adult hospitalizations for elective coronary artery bypass grafting/valve operations were tabulated from the 2010-2020 Nationwide Readmissions Database. Patients were stratified into quartiles of income, with records in the 76th to 100th percentile designated as highest and those in the 0 to 25th percentile as lowest. To evaluate the change in adjusted risk of in-hospital mortality, complications, and readmission over the study period, estimates were generated for each income level and year.

Results

Of approximately 1,848,755 hospitalizations, 406,216 patients (22.0%) were classified as highest income and 451,988 patients (24.4%) were classified as lowest income. After risk adjustment, lowest income remained associated with greater likelihood of in-hospital mortality (adjusted odds ratio, 1.61, 95% CI, 1.51-1.72), any postoperative complication (adjusted odds ratio, 1.19, CI, 1.15-1.22), and nonelective readmission within 30 days (adjusted odds ratio, 1.07, CI, 1.05-1.10). Overall adjusted risk of mortality, complications, and nonelective readmission decreased for both groups from 2010 to 2020 (P < .001). Further, the difference in risk of mortality between patients of lowest and highest income decreased by 0.2%, whereas the difference in risk of major complications declined by 0.5% (both P < .001).

Conclusions

Although overall in-hospital mortality and complication rates have declined, low-income patients continue to face greater postoperative risk. Novel interventions are needed to address continued income-based disparities and ensure equitable surgical outcomes.

目标尽管国家一直在努力提高住院患者手术的安全性,但基于收入的手术结果不平等现象依然存在,而且这种不平等现象的演变尚未在当代环境中得到研究。我们试图研究过去十年中社区家庭收入与心脏手术急性结果的关系。方法从 2010-2020 年全国再入院数据库中统计了所有选择性冠状动脉旁路移植/瓣膜手术的成人住院患者。将患者按收入四分位数进行分层,第76到第100个百分位数的记录为最高记录,第0到第25个百分位数的记录为最低记录。结果 在约 1,848,755 例住院患者中,406,216 例患者(22.0%)被归类为最高收入,451,988 例患者(24.4%)被归类为最低收入。经过风险调整后,收入最低的患者仍然更有可能出现院内死亡(调整后的几率比为 1.61,95% CI 为 1.51-1.72)、术后并发症(调整后的几率比为 1.19,CI 为 1.15-1.22)和 30 天内非选择性再入院(调整后的几率比为 1.07,CI 为 1.05-1.10)。从 2010 年到 2020 年,两组患者的死亡率、并发症和非选择性再入院的总体调整风险均有所下降(P < .001)。此外,收入最低和收入最高的患者之间的死亡率风险差异下降了 0.2%,而主要并发症的风险差异下降了 0.5%(均为 P < .001)。需要采取新的干预措施来解决持续存在的收入差距问题,并确保公平的手术结果。
{"title":"Persistent income-based disparities in clinical outcomes of cardiac surgery across the United States: A contemporary appraisal","authors":"Sara Sakowitz MS, MPH ,&nbsp;Syed Shahyan Bakhtiyar MD, MBE ,&nbsp;Saad Mallick MD ,&nbsp;Arjun Verma BS ,&nbsp;Yas Sanaiha MD ,&nbsp;Richard Shemin MD ,&nbsp;Peyman Benharash MD","doi":"10.1016/j.xjon.2024.05.015","DOIUrl":"10.1016/j.xjon.2024.05.015","url":null,"abstract":"<div><h3>Objective</h3><p>Although national efforts have aimed to improve the safety of inpatient operations, income-based inequities in surgical outcomes persist, and the evolution of such disparities has not been examined in the contemporary setting. We sought to examine the association of community-level household income with acute outcomes of cardiac procedures over the past decade.</p></div><div><h3>Methods</h3><p>All adult hospitalizations for elective coronary artery bypass grafting/valve operations were tabulated from the 2010-2020 Nationwide Readmissions Database. Patients were stratified into quartiles of income, with records in the 76th to 100th percentile designated as highest and those in the 0 to 25th percentile as lowest. To evaluate the change in adjusted risk of in-hospital mortality, complications, and readmission over the study period, estimates were generated for each income level and year.</p></div><div><h3>Results</h3><p>Of approximately 1,848,755 hospitalizations, 406,216 patients (22.0%) were classified as highest income and 451,988 patients (24.4%) were classified as lowest income. After risk adjustment, lowest income remained associated with greater likelihood of in-hospital mortality (adjusted odds ratio, 1.61, 95% CI, 1.51-1.72), any postoperative complication (adjusted odds ratio, 1.19, CI, 1.15-1.22), and nonelective readmission within 30 days (adjusted odds ratio, 1.07, CI, 1.05-1.10). Overall adjusted risk of mortality, complications, and nonelective readmission decreased for both groups from 2010 to 2020 (<em>P &lt;</em> .001). Further, the difference in risk of mortality between patients of lowest and highest income decreased by 0.2%, whereas the difference in risk of major complications declined by 0.5% (both <em>P</em> &lt; .001).</p></div><div><h3>Conclusions</h3><p>Although overall in-hospital mortality and complication rates have declined, low-income patients continue to face greater postoperative risk. Novel interventions are needed to address continued income-based disparities and ensure equitable surgical outcomes.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"20 ","pages":"Pages 89-100"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624001645/pdfft?md5=723790c8994ad7023d4a42089a7ee72d&pid=1-s2.0-S2666273624001645-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141961059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient-reported outcome measures after minimally invasive mitral valve surgery: The benefit may be early 微创二尖瓣手术后的患者报告结果测量:早期获益
Pub Date : 2024-08-01 DOI: 10.1016/j.xjon.2024.05.010
Amy Brown MD, MSc, MPH, Rhys I. Beaudry PhD, Jolene Moen RN, Sean Kang MSc, Ali Fatehi Hassanabad MD, MSc, Vishnu Vasanthan MD, Alexander J. Gregory MD, William D.T. Kent MD, MSc, Corey Adams MD, MSc
{"title":"Patient-reported outcome measures after minimally invasive mitral valve surgery: The benefit may be early","authors":"Amy Brown MD, MSc, MPH,&nbsp;Rhys I. Beaudry PhD,&nbsp;Jolene Moen RN,&nbsp;Sean Kang MSc,&nbsp;Ali Fatehi Hassanabad MD, MSc,&nbsp;Vishnu Vasanthan MD,&nbsp;Alexander J. Gregory MD,&nbsp;William D.T. Kent MD, MSc,&nbsp;Corey Adams MD, MSc","doi":"10.1016/j.xjon.2024.05.010","DOIUrl":"10.1016/j.xjon.2024.05.010","url":null,"abstract":"","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"20 ","pages":"Pages 26-28"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266627362400130X/pdfft?md5=479745961e97555770e1f148eae456d8&pid=1-s2.0-S266627362400130X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141961060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncologic outcomes after minimally invasive segmentectomy or lobectomy in patients with hypermetabolic clinical stage IA1-2 non–small cell lung cancer 高代谢临床IA1-2期非小细胞肺癌患者微创肺段切除术或肺叶切除术后的肿瘤治疗效果
Pub Date : 2024-08-01 DOI: 10.1016/j.xjon.2024.05.002

Objective

To evaluate the oncologic outcome of patients with hypermetabolic tumors resected by segmentectomy or lobectomy.

Methods

This was a retrospective analysis of all consecutive patients with peripheral clinical stage IA1-2 non–small cell lung cancer (January 2017-June 2023) who underwent resection by segmentectomy or lobectomy in a single center. A hypermetabolic tumor was defined as a tumor with a positron emission tomography (PET) maximum standardized uptake value >2.5. Propensity score case-matching analysis was used to generate 2 balanced groups of patients with hypermetabolic tumors operated by segmentectomy or lobectomy. Four-year overall survival (OS), event-free survival (EFS), and cancer-specific survival were compared between the matched groups.

Results

A total of 164 segmentectomies and 234 lobectomies were analyzed. There were 91 (55%) hypermetabolic tumors in the segmentectomy group versus 178 in the lobectomy group (76%), P < .001. The comparison of the matched groups with hypermetabolic tumors showed a better 4-year OS after lobectomy compared with segmentectomy (lobectomy 87%; 95% confidence interval [CI], 76-93; segmentectomy, 67%; 95% CI, 49-80; P = .029). The 4-year EFS appeared to have a better trend after lobectomy (77%; 95% CI, 65-85) compared with segmentectomy (58%; 95% CI, 39-72), P = .088. The 4-year cancer-specific survival, however, was similar between the matched groups (lobectomy, 95%; 95% CI, 86-98 vs segmentectomy, 94%; 95% CI, 78-99, P = .79).

Conclusions

Early-stage peripheral hypermetabolic tumors are associated with poorer oncologic outcomes compared with less PET-avid tumors. Despite poorer OS and EFS after segmentectomy likely caused by cancer-unrelated deaths, cancer-specific survival in this high-risk group was similar after lobectomy or segmentectomy. In well-selected patients, a high PET maximum standardized uptake value should not be considered a contraindication to segmentectomy.

方法这是一项回顾性分析,对象是在一个中心接受分段切除术或肺叶切除术的所有外周临床IA1-2期非小细胞肺癌连续患者(2017年1月至2023年6月)。高代谢肿瘤被定义为正电子发射断层扫描(PET)最大标准化摄取值为>2.5的肿瘤。通过倾向评分病例匹配分析,产生了两组均衡的高代谢肿瘤患者,他们分别接受了分段切除术或肺叶切除术。对匹配组的四年总生存率(OS)、无事件生存率(EFS)和癌症特异性生存率进行了比较。分段切除组中有 91 例(55%)高代谢肿瘤,而肺叶切除组中有 178 例(76%),P <.001。高代谢肿瘤配对组的比较显示,与分段切除术相比,肺叶切除术后的4年OS更好(肺叶切除术87%;95%置信区间[CI],76-93;分段切除术67%;95% CI,49-80;P = .029)。与分段切除术(58%;95% CI,39-72)相比,肺叶切除术(77%;95% CI,65-85)后的 4 年 EFS 似乎有更好的趋势,P = .088。结论早期外周高代谢肿瘤与PETavid较低的肿瘤相比,其肿瘤学预后较差。尽管分段切除术后的OS和EFS较差,这可能是由于与癌症无关的死亡造成的,但这一高危人群在肺叶切除术或分段切除术后的癌症特异性生存率相似。在经过严格筛选的患者中,PET最大标准化摄取值较高不应被视为分段切除术的禁忌症。
{"title":"Oncologic outcomes after minimally invasive segmentectomy or lobectomy in patients with hypermetabolic clinical stage IA1-2 non–small cell lung cancer","authors":"","doi":"10.1016/j.xjon.2024.05.002","DOIUrl":"10.1016/j.xjon.2024.05.002","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the oncologic outcome of patients with hypermetabolic tumors resected by segmentectomy or lobectomy.</p></div><div><h3>Methods</h3><p>This was a retrospective analysis of all consecutive patients with peripheral clinical stage IA1-2 non–small cell lung cancer (January 2017-June 2023) who underwent resection by segmentectomy or lobectomy in a single center. A hypermetabolic tumor was defined as a tumor with a positron emission tomography (PET) maximum standardized uptake value &gt;2.5. Propensity score case-matching analysis was used to generate 2 balanced groups of patients with hypermetabolic tumors operated by segmentectomy or lobectomy. Four-year overall survival (OS), event-free survival (EFS), and cancer-specific survival were compared between the matched groups.</p></div><div><h3>Results</h3><p>A total of 164 segmentectomies and 234 lobectomies were analyzed. There were 91 (55%) hypermetabolic tumors in the segmentectomy group versus 178 in the lobectomy group (76%), <em>P</em> &lt; .001. The comparison of the matched groups with hypermetabolic tumors showed a better 4-year OS after lobectomy compared with segmentectomy (lobectomy 87%; 95% confidence interval [CI], 76-93; segmentectomy, 67%; 95% CI, 49-80; <em>P</em> = .029). The 4-year EFS appeared to have a better trend after lobectomy (77%; 95% CI, 65-85) compared with segmentectomy (58%; 95% CI, 39-72), <em>P</em> = .088. The 4-year cancer-specific survival, however, was similar between the matched groups (lobectomy, 95%; 95% CI, 86-98 vs segmentectomy, 94%; 95% CI, 78-99, <em>P</em> = .79).</p></div><div><h3>Conclusions</h3><p>Early-stage peripheral hypermetabolic tumors are associated with poorer oncologic outcomes compared with less PET-avid tumors. Despite poorer OS and EFS after segmentectomy likely caused by cancer-unrelated deaths, cancer-specific survival in this high-risk group was similar after lobectomy or segmentectomy. In well-selected patients, a high PET maximum standardized uptake value should not be considered a contraindication to segmentectomy.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"20 ","pages":"Pages 167-173"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624001220/pdfft?md5=40682cf1a1bc1e6fc266fe416da171a5&pid=1-s2.0-S2666273624001220-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141141281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Greater ipsilateral rectus muscle atrophy after robotic thoracic surgery compared with open and video-assisted thoracoscopic surgery approaches 与开放式和视频辅助胸腔镜手术方法相比,机器人胸腔镜手术后同侧直肌萎缩更严重
Pub Date : 2024-08-01 DOI: 10.1016/j.xjon.2024.05.011
Yoyo Wang BS , Ryan J. Randle MD , Prasha Bhandari MPH , Hao He PhD , Winston L. Trope BA , Brandon A. Guenthart MD , H. Henry Guo MD , Douglas Z. Liou MD , Leah M. Backhus MD , Mark F. Berry MD , Joseph B. Shrager MD , Natalie S. Lui MD

Objective

Robotic thoracic surgery provides another minimally invasive approach in addition to video-assisted thoracoscopic surgery (VATS) that yields less pain and faster recovery compared with open surgery. However, robotic incisions are generally placed more inferiorly, which may increase the risk of intercostal nerve injury that affects the abdominal wall. We hypothesized that a robotic approach causes greater ipsilateral rectus muscle atrophy compared with open and VATS approaches.

Methods

The cross-sectional area and density of bilateral rectus abdominis muscles were measured on computed tomography scans in patients who underwent lobectomy in 2018. The differences between the contralateral and ipsilateral muscles were compared between preoperative and 6-month surveillance scans. Changes were compared among the open, VATS, and robotic approaches through a mixed effects model after adjustments of correlation and covariates.

Results

Of 99 lobectomies, 25 (25.3%) were open, 56 (56.6%) VATS, and 18 (18.1%) robotic. The difference between the contralateral and ipsilateral rectus muscle cross-sectional area was significantly larger at 6 months after robotic surgery compared with open (31.4% vs 9.5%, P = .049) and VATS (31.4% vs 14.1%, P = .021). There were no significant differences in the cross-sectional area between the open and VATS approach.

Conclusions

In this retrospective analysis, there was greater ipsilateral rectus muscle atrophy associated with robotic thoracic surgery compared with open or VATS approaches. These findings should be correlated with clinical symptoms and followed to assess for resolution or persistence.

目的除视频辅助胸腔镜手术(VATS)外,机器人胸腔镜手术提供了另一种微创方法,与开放手术相比,机器人胸腔镜手术疼痛更轻、恢复更快。然而,机器人切口一般放置在更靠下的位置,这可能会增加肋间神经损伤的风险,从而影响腹壁。我们假设,与开腹和VATS方法相比,机器人方法会导致同侧腹直肌萎缩程度更大。方法通过计算机断层扫描测量了2018年接受肺叶切除术的患者双侧腹直肌的横截面积和密度。比较术前扫描和 6 个月监测扫描中对侧肌肉和同侧肌肉的差异。在调整相关性和协变量后,通过混合效应模型比较了开放式、VATS 和机器人方法之间的变化。结果 在 99 例肺叶切除术中,25 例(25.3%)为开放式,56 例(56.6%)为 VATS,18 例(18.1%)为机器人。与开腹手术(31.4% vs 9.5%,P = .049)和VATS手术(31.4% vs 14.1%,P = .021)相比,机器人手术后6个月,对侧和同侧直肌横截面积的差异显著增大。结论在这项回顾性分析中,与开放式或 VATS 方法相比,机器人胸腔镜手术导致的同侧直肌萎缩更严重。这些发现应与临床症状相关联,并进行跟踪以评估症状是否缓解或持续。
{"title":"Greater ipsilateral rectus muscle atrophy after robotic thoracic surgery compared with open and video-assisted thoracoscopic surgery approaches","authors":"Yoyo Wang BS ,&nbsp;Ryan J. Randle MD ,&nbsp;Prasha Bhandari MPH ,&nbsp;Hao He PhD ,&nbsp;Winston L. Trope BA ,&nbsp;Brandon A. Guenthart MD ,&nbsp;H. Henry Guo MD ,&nbsp;Douglas Z. Liou MD ,&nbsp;Leah M. Backhus MD ,&nbsp;Mark F. Berry MD ,&nbsp;Joseph B. Shrager MD ,&nbsp;Natalie S. Lui MD","doi":"10.1016/j.xjon.2024.05.011","DOIUrl":"10.1016/j.xjon.2024.05.011","url":null,"abstract":"<div><h3>Objective</h3><p>Robotic thoracic surgery provides another minimally invasive approach in addition to video-assisted thoracoscopic surgery (VATS) that yields less pain and faster recovery compared with open surgery. However, robotic incisions are generally placed more inferiorly, which may increase the risk of intercostal nerve injury that affects the abdominal wall. We hypothesized that a robotic approach causes greater ipsilateral rectus muscle atrophy compared with open and VATS approaches.</p></div><div><h3>Methods</h3><p>The cross-sectional area and density of bilateral rectus abdominis muscles were measured on computed tomography scans in patients who underwent lobectomy in 2018. The differences between the contralateral and ipsilateral muscles were compared between preoperative and 6-month surveillance scans. Changes were compared among the open, VATS, and robotic approaches through a mixed effects model after adjustments of correlation and covariates.</p></div><div><h3>Results</h3><p>Of 99 lobectomies, 25 (25.3%) were open, 56 (56.6%) VATS, and 18 (18.1%) robotic. The difference between the contralateral and ipsilateral rectus muscle cross-sectional area was significantly larger at 6 months after robotic surgery compared with open (31.4% vs 9.5%, <em>P</em> = .049) and VATS (31.4% vs 14.1%, <em>P</em> = .021). There were no significant differences in the cross-sectional area between the open and VATS approach.</p></div><div><h3>Conclusions</h3><p>In this retrospective analysis, there was greater ipsilateral rectus muscle atrophy associated with robotic thoracic surgery compared with open or VATS approaches. These findings should be correlated with clinical symptoms and followed to assess for resolution or persistence.</p></div>","PeriodicalId":74032,"journal":{"name":"JTCVS open","volume":"20 ","pages":"Pages 202-209"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666273624001311/pdfft?md5=b8117a758f48bb0120e84f964c3dc660&pid=1-s2.0-S2666273624001311-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141961057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JTCVS open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1